Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Restructuring Costs of $5.2 million for Q1 2026, up 802.45% year-over-year from $571000.0 in Q1 2025, and up 108.62% quarter-over-quarter from $2.5 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Restructuring Costs history runs 10 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Restructuring Costs rose 802.45% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $8.8 million (up 503.71% YoY), while the FY2025 annual figure was $4.2 million, up 78.68% from the prior year.
- Restructuring Costs for Q1 2026 stood at $5.2 million, up from $2.5 million in the prior quarter.
- The five-year high for Restructuring Costs was $5.2 million in Q1 2026, with the low at -$612000.0 in Q4 2022.
- The 5-year median for Restructuring Costs is $540500.0 (2023), against an average of $885312.5.
- The sharpest annual moves came in 2022 and 2026: Restructuring Costs plunged 108.37% in 2022, then soared 802.45% in 2026.
- Amneal Pharmaceuticals' Restructuring Costs stood at -$612000.0 in 2022, then surged by 118.63% to $114000.0 in 2023, then soared by 332.46% to $493000.0 in 2024, then soared by 401.01% to $2.5 million in 2025, then soared by 108.62% to $5.2 million in 2026.
- Business Quant data shows AMRX's Restructuring Costs at $5.2 million in Q1 2026, $2.5 million in Q4 2025, and $143000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.55 Bn | 334.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.60 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 571,000.00 |
| Dec 31, 2024 | 493,000.00 |
| Sep 30, 2024 | 172,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 114,000.00 |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 82,000.00 |
| Mar 31, 2023 | 510,000.00 |
| Dec 31, 2022 | -612,000.00 |
| Sep 30, 2022 | 581,000.00 |
| Mar 31, 2022 | 731,000.00 |
| Dec 31, 2021 | 7.31 Mn |
| Sep 30, 2021 | 425,000.00 |
| Mar 31, 2021 | 363,000.00 |